Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX26F6WTJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $81,250
Award facts
- Contract value 100% obligated
- $81,249.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $81,249.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 17, 2025, carries an ultimate completion date of November 7, 2025, and was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. was selected as the awardee based on its established performance as a regional prime vendor contractor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency, designated as contract SPE2DR, which carries a $499.999 billion ceiling value through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical products, including biologics, branded and generic medications, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's extensive product portfolio and demonstrated performance across numerous delivery orders position the company as a critical pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DX26F6WTJ?
SPE2DX26F6WTJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 17, 2025.
How much is contract SPE2DX26F6WTJ worth?
The government has obligated $81,250 on SPE2DX26F6WTJ.
Is contract SPE2DX26F6WTJ an order under another contract?
Yes. SPE2DX26F6WTJ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX26F6WTJ competed?
The extent of competition for SPE2DX26F6WTJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award